Found: 5
Select item for more details and to access through your institution.
Experience With Four-Month Rifapentine and Moxifloxacin–Based Tuberculosis Treatment in San Francisco.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 4, p. 1, doi. 10.1093/ofid/ofae178
- By:
- Publication type:
- Article
Adverse Events Associated With Treatment for Pan-Susceptible Tuberculosis in San Francisco.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 6, p. 1121, doi. 10.1093/cid/ciac867
- By:
- Publication type:
- Article
Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California, USA.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 8, p. 1651, doi. 10.3201/eid2908.230347
- By:
- Publication type:
- Article
Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months -- California, January-March, 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 72, n. 52/53, p. 1390, doi. 10.15585/mmwr.mm725253a2
- By:
- Publication type:
- Article